A detailed history of Exodus Point Capital Management, LP transactions in Celcuity Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 691,451 shares of CELC stock, worth $9.12 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
691,451
Previous 429,934 60.83%
Holding current value
$9.12 Million
Previous $7.04 Million 46.41%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.98 - $19.15 $3.66 Million - $5.01 Million
261,517 Added 60.83%
691,451 $10.3 Million
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $1.44 Million - $2.12 Million
101,870 Added 31.05%
429,934 $7.04 Million
Q1 2024

May 14, 2024

BUY
$13.74 - $21.6 $4.51 Million - $7.09 Million
328,064 New
328,064 $7.09 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $197M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.